A Case Report of Anti-TIF1-γAntibody-Positive Dermatomyositis Concomitant with Small Cell Neuroendocrine Carcinoma of the Urinary Bladder

Small cell neuroendocrine carcinoma is rare among urinary bladder cancer types, and to date, there are no case reports of concurrent antitranscriptional intermediary factor 1-γantibody-positive dermatomyositis. We describe the case of a 69-year-old Japanese man who presented with elevated creatine kinase levels and haematuria on medical examination. Approximately one month later, he developed dysphagia. Laryngoscopy confirmed laryngeal dysfunction. He also presented with muscle weakness and a skin rash. Magnetic resonance imaging of the upper extremities suggested bilateral brachial muscle myositis. He was diagnosed as having dermatomyositis and was later found to be positive for antitranscriptional intermediary factor 1-γ antibody. Computed tomography revealed an intravesical space-occupying lesion and right iliac lymphadenopathy, suggesting urinary bladder cancer. The patient was admitted to our hospital for treatment. Urinary bladder biopsy confirmed small cell neuroendocrine carcinoma because tumour cells were positive for synaptophysin, CD56, and chromogranin A. Thus, the patient was diagnosed as having an antitranscriptional intermediary factor 1-γantibody-positive dermatomyositis concomitant with urinary bladder small cell neuroendocrine carcinoma. The patient was treated with glucocorticoid and intravenous immune globulin therapy for dermatomyositis. Radiotherapy was selected for the carcinoma. Although muscle weakness and skin symptoms improved with treatment, dysphagia persisted. Furthermore, expression of the transcriptional intermediary factor 1-γ protein in tumour cells was also confirmed by immunohistochemistry, but the significance is unknown. It should be noted that antitranscriptional intermediary factor 1-γantibody-positive dermatomyositis can occur concomitantly with such a rare malignancy

Predictive factors for complications after surgical treatment for schwannomas of the extremities

Abstract Background Schwannomas are well-encapsulated, benign neoplasms, and enucleation is a standard operation procedure. The incidence of neurological complications after surgical treatment for schwannomas of the extremities varies, and there is no consensus concerning predictive factors for complications. The aim of this study was to elucidate predictive factors for complications after surgical treatment of schwannomas that develop in the major nerves of the extremities. Methods A total of 139 patients with 141 schwannomas arising in major nerves were retrospectively analyzed. Data regarding preoperative clinical features, the postoperative neurological complications, and clinical course of complications, with a median follow-up period of 2 months (range, 0.5–96), were obtained. Predictive factors for complications were statistically analyzed. Results Postoperative complications occurred in 49 lesions (34.8%), including 42 with sensory disturbance and 8 with motor weakness. In univariate analysis, older age, tumors originating from the upper extremity, and major motor nerve involvement were associated with a higher complication rate (p = 0.03, p = 0.003, and p = 0.001, respectively). In multivariate analysis, major motor nerve involvement was an independent predictive factor for postoperative complications (p = 0.03). Almost all complications gradually improved, but 6 out of 8 patients with motor weakness did not show full recovery at the final follow-up. Conclusions Schwannomas originating from major motor nerves can lead to a higher risk for postoperative complications

The Bess-Polar II Long Duration Flight Above Antarctica

The Balloon-borne Experiment with a Superconducting Spectrometer, BESS, has been developed to study elementary particle phenomena in the early universe through measurements of low energy antiprotons to investigate their origin and through a search for antihelium. The BESS collaboration carried out nine northern latitude flights between 1993 and 2002. BESS-Polar is an advanced program of the BESS collaboration to study these topics with much greater precision using long duration flights above Antarctica. The BESS-Polar spectrometer was successfully developed to accumulate much larger numbers of events during long duration flights around the South Pole. Approximately a factor of four reductions in the amount of material in the particle beam enables measurement of much lower energy antiprotons down to 100 MeV (at top of atmosphere). The first BESS-Polar flight (BESS-Polar I) of 8.5 days was carried out above Antarctica in December 2004. recording 900 million cosmic-ray events. The second BESS-Polar flight (BESS-Polar 11) was successfully carried out in the austral summer season of 2007-2008. Based on experience with BESS-Polar I, the spectrometer was improved in performance and achieved long term stability during the flight. A newly constructed magnet with a larger liquid He capacity and improved thermal insulation and an upgraded data storage system with larger capacity of hard disk drives (HDDs) enabled longer observation time. BESS-Polar II was launched on December 22, 2007 from Williams Field, McMurdo Station, in Antarctica. The spectrometer worked properly and observed cosmic rays for about 24.5 days at float altitude, recording 4.6 billion events on the HDDs until the limit of the magnet operation was reached on January 16, 2008. The flight was terminated and the spectrometer was safely landed on the West Antarctic ice sheet (1000 km from the South Pole) on January 21, 2008. Here, the BESS-Polar instrument is discussed, highlighting improvements made for BESS-Polar II, and overviews of the flight and performance are reported

The Bess Investigation of the Origin of Cosmic-ray Antiprotons and Search for Cosmological Antimatter

The Balloon-borne Experiment with a Superconducting Spectrometer (BESS) collaboration has made precise measurements of the spectra of cosmic ray antiprotons and light nuclei and conducted a sensitive search for antinuclei. Ten BESS high-latitude flights, eight from Canada and two from Antarctica, span more than a Solar cycle between 1993 and 2007/2008. BESS measurements of low-energy antiprotons constrain candidate models for dark matter including the possible signature of primordial black hole evaporation. The stringent BESS measurements of antiprotons and the elemental and isotopic spectra of H and He provide strong constraints on models of cosmic-ray transport in the Galaxy and Solar System. BESS has also reported the first antideuterium upper limit. BESS employs a superconducting magnetic-rigity spectrometer with time-of-flight and aerogel Cherenkov detectors to identify incident particles by charge, charge sign, mass, and energy. The BESS-Polar long-duration instrument has reduced lower energy limit of 100 MeV (top of the atmosphere) to increase its sensitivity to possible primary antiproton sources. BESS-Polar II was rebuilt with extended magnet lifetime, improved detector and electronic performance, and greater data storage capacity. It was flown fro Antarctica December 2007-January 2008, recording about 4.6 bission events during 24.5 days at float altitude with the magnet on. During the flight the influence of a high-speed stream in the Solar wind was observed. Details of the BESS-Polar II instrument and flight performance are reported elsewhere at this conference. The successful BESS-Polar II flight at Solar minimum is especially important. Most cosmic-ray antiprotons are secondary products of nuclear interactions of primary cosmic-ray nuclei with the interstellar gas, giving a spectrum that peaks at about 2 GeV and falls rapidly to higher and lower energies. However, BESS data taken in the previous Solar minimum show a small excess over secondary expectations at low energies, possibly suggesting the presence of an additional component that may be masked at higher levels of Solar modulation. The high-statistics Solar minimum data obtained by BESS-Polar II will provide a difinitive test of this component. We will review the BESS program and report the latest results including the antiproton and proton spectra measured in the BESS-Polar I flight, the search for cosmic antinuclei, and the status of the BESS-Polar II analysis